A detailed history of Israel Englander (Millennium Management LLC) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 75,613 shares of SWTX stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,613
Previous 14,714 413.88%
Holding current value
$2.78 Million
Previous $554,000 337.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $1.95 Million - $2.6 Million
60,899 Added 413.88%
75,613 $2.42 Million
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $24.9 Million - $32.9 Million
-690,825 Reduced 97.91%
14,714 $554,000
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $24.5 Million - $35.2 Million
671,334 Added 1962.68%
705,539 $34.7 Million
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $647,842 - $1.27 Million
34,205 New
34,205 $1.25 Million
Q1 2023

May 15, 2023

BUY
$24.97 - $34.05 $334,822 - $456,576
13,409 Added 9.84%
149,655 $3.85 Million
Q4 2022

Feb 14, 2023

SELL
$21.73 - $28.72 $746,447 - $986,560
-34,351 Reduced 20.14%
136,246 $3.54 Million
Q3 2022

Nov 14, 2022

BUY
$24.1 - $39.66 $2.58 Million - $4.24 Million
106,925 Added 167.93%
170,597 $4.87 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $1.17 Million - $3.82 Million
63,672 New
63,672 $1.57 Million
Q1 2022

May 16, 2022

SELL
$48.97 - $65.46 $734,060 - $981,245
-14,990 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$53.3 - $75.84 $1.64 Million - $2.33 Million
-30,767 Reduced 67.24%
14,990 $929,000
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $2.87 Million - $4.04 Million
45,757 New
45,757 $2.9 Million
Q2 2021

Aug 16, 2021

SELL
$67.45 - $85.63 $5.26 Million - $6.68 Million
-77,990 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$65.1 - $93.59 $2.76 Million - $3.97 Million
-42,403 Reduced 35.22%
77,990 $5.74 Million
Q4 2020

Feb 16, 2021

SELL
$48.36 - $77.92 $1.88 Million - $3.02 Million
-38,812 Reduced 24.38%
120,393 $8.73 Million
Q3 2020

Nov 16, 2020

SELL
$36.14 - $51.99 $4.8 Million - $6.9 Million
-132,803 Reduced 45.48%
159,205 $7.59 Million
Q2 2020

Aug 14, 2020

BUY
$22.98 - $48.57 $5.31 Million - $11.2 Million
231,248 Added 380.59%
292,008 $12.3 Million
Q1 2020

May 14, 2020

BUY
$20.44 - $41.21 $1.12 Million - $2.27 Million
55,037 Added 961.68%
60,760 $1.64 Million
Q4 2019

Feb 14, 2020

SELL
$17.74 - $39.52 $7.06 Million - $15.7 Million
-397,890 Reduced 98.58%
5,723 $220,000
Q3 2019

Nov 14, 2019

BUY
$18.8 - $27.82 $7.59 Million - $11.2 Million
403,613 New
403,613 $8.75 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.3B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.